#GLP-1 Medications

Bariatric Surgery: Still the Gold Standard for Obesity Treatment in the GLP-1 Era, Experts Affirm in 2026

In an age captivated by the promise of GLP-1 medications, leading experts have reaffirmed that bariatric surgery remains the definitive 'gold standard' for treating obesity. This assertion, made on February 14, 2026, highlights the surgery's unmatched efficacy, durability, and profound health benefits, even as pharmaceutical innovations continue to evolve.